LarryWTsaiMD

Pulmonology • Boston, MA

Critical Care Medicine, Pleural Disease

Instructor in Medicine, Brigham and Women's Hospital

Join to view full profile

Dr. Tsai is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Tsai's full profile

Already have an account?

Office
75 Francis Street Pbb Clinics 3
Brigham And Women's Hospital Pulmonary Division
Boston, MA 02115
Phone+1 617-732-5500

Education & Training

Massachusetts General Hospital/BIDMC/Harvard Medical SchoolFellowship, Pulmonary Disease and Critical Care Medicine, 2001 - 2003
Brigham and Women's HospitalResidency, Internal Medicine, 1997 - 2000
Harvard Medical SchoolClass of 1997

Certifications & Licensure

CA State Medical License 2000 - 2025
MA State Medical License 1999 - 2025
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Pulmonary Disease

Clinical Trials

A Phase 1 TP-271 Oral PK Multiple Ascending Dose Study Start of enrollment: 2018 Mar 20
Completed
Phase 1

Publications & Presentations

PubMed

20 citations
Prognostic and Predictive Biomarkers in Patients With Coronavirus Disease 2019 Treated With Tocilizumab in a Randomized Controlled Trial.
Jennifer Tom, Min Bao, Larry W. Tsai, Aditi Qamra, David Summers
Critical Care Medicine. 2021-10-12
8 citations
Mass Balance and Drug Interaction Potential of Intravenous Eravacycline Administered to Healthy Subjects.
Joseph V. Newman, Jian Zhou, Sergey Izmailyan, Larry W. Tsai
Antimicrobial Agents and Chemotherapy. 2019-02-26
24 citations
Randomized, Double-Blind, Placebo-Controlled Studies of the Safety and Pharmacokinetics of Single and Multiple Ascending Doses of Eravacycline.
Joseph V. Newman, Jian Zhou, Sergey Izmailyan, Larry Tsai
Antimicrobial Agents and Chemotherapy. 2018-10-24

Journal Articles

Tocilizumab in Hospitalized Patients with Severe Covid-19 Pneumonia
Ivan O Rosas, Ronaldo C Go, Ivor S Douglas, Larry Tsai, Atul Malhotra, The New England Journal of Medicine

Press Mentions

Tetraphase Pharmaceuticals Announces Corporate Reorganization Aimed at Maximizing XERAVA™ (Eravacycline) Commercial OpportunityJune 12th, 2019
Tetraphase Pharmaceuticals Announces New XERAVA™ (Eravacycline) Data at the 39June 10th, 2019
Weekly Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH) Ratings on Dec 15, 2018December 15th, 2018
Join now to see all